Solventum is currently trading at a significant discount compared to its medical technology peers, with a forward price-to-earnings ratio of about 13 times and low EV/EBITDA multiples. The company’s management is actively optimizing its portfolio, including plans to potentially spin off its Health Information Systems segment to unlock shareholder value and reduce debt. Additionally, Solventum has raised its earnings per share guidance for 2026 to between $7.10 and $7.20 and expects operating margins to expand to 22.2%-22.7%, indicating improved profitability and better free cash flow management. Based on these factors, a long position is recommended with a 12 to 18-month price target of $120.91, suggesting approximately 41% upside from current levels.
Solventum's recent strategic moves provide context for readers interested in health-related equities. For readers following the health sector, here is Pluang's market snapshot as of Sep 18, 2026 18:41 WIB: Among 92 priced US health-sector stocks tradable on Pluang, 39 advanced and 42 declined. Notable movers include ADMA Biologics Inc at USD 9.15 with a 2.23% increase and 100% buy order activity, Citius Pharmaceuticals Inc at USD 0.60 with a 2.06% rise but 100% sell order activity, and Ginkgo Bioworks Holdings Inc at USD 7.98 with a 1.79% gain and full buy order activity. Typical hold times range from 11 to 18 days.
Rheinmetall AG is a key beneficiary of Europe's increased and sustained defense spending, with a diverse portfolio including ammunition, military vehicles, air defense, and digital systems. The company has a substantial €80.5 billion order backlog an...
Warren Buffett has transitioned to chairman emeritus of Berkshire Hathaway after leading the company for over 60 years. His son, Howard Buffett, becomes the new board chair, while Greg Abel continues as CEO, running the company’s operations. This mov...
RBC Capital Markets maintains an 'underperform' rating on Vistry Group PLC with a price target of 180p, below the current share price of 271.60p. The upcoming half-year results and new CEO Adam Daniels's strategic review are highly anticipated, seen ...
Boeing's shares fell after CEO Kelly Ortberg revealed that stabilizing 737 MAX production is taking longer than expected, causing a recent 2.43% drop and an 11.66% decline over the past month. Despite these setbacks and a challenging 2026 with losses...
The XRP Ledger has introduced a new lending feature allowing XRP holders to lock their tokens in closed-ended vaults for fixed periods, potentially up to 30 years. While locked XRP remains part of the total supply and is not burned, it reduces the li...
